Skip to main content

Casper Marc N's Form 4 filing

Thermo Fisher Scientific Inc. (TMO) · filed Mar 15, 2023

Accession no.
0001127602-23-010280
Filed
Mar 15, 2023
Trade date
Mar 13-14, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 23 non-derivative transactions. Open-market sales total $8.24M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Casper Marc NCIK 0001216055Director, Officer (Chairman & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 13, 2023Common StockSSaleDisposed−300$538.27F2−$161,48173,855Indirect
Mar 13, 2023Common StockSSaleDisposed−200$540.26F3−$108,05273,655Indirect
Mar 13, 2023Common StockSSaleDisposed−716$541.28F4−$387,556.4872,939Indirect
Mar 13, 2023Common StockSSaleDisposed−1,300$542.40F5−$705,12071,639Indirect
Mar 13, 2023Common StockSSaleDisposed−1,584$544.34F6−$862,234.5670,055Indirect
Mar 13, 2023Common StockSSaleDisposed−1,300$545.33F7−$708,92968,755Indirect
Mar 13, 2023Common StockSSaleDisposed−600$546.45F8−$327,87068,155Indirect
Mar 13, 2023Common StockSSaleDisposed−700$547.34F9−$383,13867,455Indirect
Mar 13, 2023Common StockSSaleDisposed−400$548.29F10−$219,31667,055Indirect
Mar 13, 2023Common StockSSaleDisposed−400$549.99F11−$219,99666,655Indirect
Mar 14, 2023Common StockSSaleDisposed−200$546.43F12−$109,28666,455Indirect
Mar 14, 2023Common StockSSaleDisposed−200$549.11F13−$109,82266,255Indirect
Mar 14, 2023Common StockSSaleDisposed−1,183$550.30F14−$651,004.965,072Indirect
Mar 14, 2023Common StockSSaleDisposed−840$551.51F15−$463,268.464,232Indirect
Mar 14, 2023Common StockSSaleDisposed−1,200$552.41F16−$662,89263,032Indirect
Mar 14, 2023Common StockSSaleDisposed−667$553.57F17−$369,231.1962,365Indirect
Mar 14, 2023Common StockSSaleDisposed−850$554.86F18−$471,63161,515Indirect
Mar 14, 2023Common StockSSaleDisposed−400$555.80F19−$222,32061,115Indirect
Mar 14, 2023Common StockSSaleDisposed−560$556.90F20−$311,86460,555Indirect
Mar 14, 2023Common StockSSaleDisposed−800$558.04F21−$446,43259,755Indirect
Mar 14, 2023Common StockSSaleDisposed−400$559.03F22−$223,61259,355Indirect
Mar 14, 2023Common StockSSaleDisposed−100$559.94−$55,99459,255Indirect
Mar 14, 2023Common StockSSaleDisposed−100$560.95−$56,09559,155Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $538.25 to $538.31, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), (20), (21) and (22) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.78 to $540.73, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $540.92 to $541.75, inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.01 to $542.96, inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $543.84 to $544.76, inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.84 to $545.82, inclusive.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $545.93 to $546.89, inclusive.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.93 to $547.87, inclusive.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.98 to $548.61, inclusive.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.69 to $550.41, inclusive.

Referenced by the price of 1 transaction in Table I.

F12

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.31 to $546.55, inclusive.

Referenced by the price of 1 transaction in Table I.

F13

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.65 to $549.56, inclusive.

Referenced by the price of 1 transaction in Table I.

F14

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.95 to $550.92, inclusive.

Referenced by the price of 1 transaction in Table I.

F15

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.02 to $551.96, inclusive.

Referenced by the price of 1 transaction in Table I.

F16

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.02 to $552.93, inclusive.

Referenced by the price of 1 transaction in Table I.

F17

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.26 to $554.00, inclusive.

Referenced by the price of 1 transaction in Table I.

F18

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.32 to $555.31, inclusive.

Referenced by the price of 1 transaction in Table I.

F19

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.40 to $556.12, inclusive.

Referenced by the price of 1 transaction in Table I.

F20

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $556.43 to $557.34, inclusive.

Referenced by the price of 1 transaction in Table I.

F21

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $557.49 to $558.40, inclusive.

Referenced by the price of 1 transaction in Table I.

F22

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $558.87 to $559.30, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)